| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ANKRD26-related thrombocytopenia 2 with a baseline increase in blasts: implications for clinical surveillance
|
Wahlster, Lara
|
|
|
146 |
2 |
p. 254-259
|
artikel
|
| 2 |
A rare phenotype of peripheral T-cell lymphoma, NOS: coexpression of CD15, CD20, and T follicular helper markers in a DUSP22 alt case
|
Al Jabri, Muna
|
|
|
146 |
2 |
p. 260
|
artikel
|
| 3 |
Beware the zombie enzyme
|
Dominguez-Sola, David
|
|
|
146 |
2 |
p. 135-136
|
artikel
|
| 4 |
Blunted CD40-responsive enhancer activation in CREBBP-mutant lymphomas can be restored by enforced CD4 T-cell engagement
|
Yang, Haopeng
|
|
|
146 |
2 |
p. 191-205
|
artikel
|
| 5 |
BRAF V600E-positive mononuclear cells in blood at diagnosis portend treatment failure and neurodegeneration in pediatric LCH
|
Lin, Howard
|
|
|
146 |
2 |
p. 206-218
|
artikel
|
| 6 |
Doubling down: the new deal in the clinical management of double-refractory chronic lymphocytic leukemia
|
Grainger, Brian T.
|
|
|
146 |
2 |
p. 145-154
|
artikel
|
| 7 |
Editorial Board
|
|
|
|
146 |
2 |
p. vi
|
artikel
|
| 8 |
Efficacy of combined CD38 and PD-1 inhibition with isatuximab and cemiplimab for relapsed/refractory NK/T-cell lymphoma
|
Kim, Seok Jin
|
|
|
146 |
2 |
p. 155-166
|
artikel
|
| 9 |
Genetic and epigenetic mechanisms of GPRC5D loss after anti-GPRC5D CAR T-cell therapy in multiple myeloma
|
Ma, Sha
|
|
|
146 |
2 |
p. 178-190
|
artikel
|
| 10 |
Iron overload impacts TCR γδ cell immunity
|
Loureiro, José Pedro
|
|
|
146 |
2 |
p. 139-140
|
artikel
|
| 11 |
Iron overload in HFE-related hemochromatosis severely impairs Vδ2+ γδ T-cell homeostasis
|
Erdogdu, Derya
|
|
|
146 |
2 |
p. 219-232
|
artikel
|
| 12 |
Masthead Subscription
|
|
|
|
146 |
2 |
p. i
|
artikel
|
| 13 |
Rapid ADAMTS13 activity assays for thrombotic thrombocytopenic purpura: a systematic review and meta-analysis
|
Deshpande, Saarang R.
|
|
|
146 |
2 |
p. 233-246
|
artikel
|
| 14 |
Real-world data provide a CARbon copy for ide-cel
|
Schmidt, Timothy
|
|
|
146 |
2 |
p. 131-133
|
artikel
|
| 15 |
Redefining risk stratification in pLCH
|
Abeykoon, Jithma P.
|
|
|
146 |
2 |
p. 136-138
|
artikel
|
| 16 |
Reshaping the TME to enhance checkpoint blockade in ENKTL
|
Dechow, Annika
|
|
|
146 |
2 |
p. 129-131
|
artikel
|
| 17 |
Silence of the myeloma clones: GPRC5D epigenetic regulation
|
Lee, Holly
|
|
|
146 |
2 |
p. 133-135
|
artikel
|
| 18 |
Standard-of-care idecabtagene vicleucel for relapsed/refractory multiple myeloma
|
Sidana, Surbhi
|
|
|
146 |
2 |
p. 167-177
|
artikel
|
| 19 |
Table of Contents
|
|
|
|
146 |
2 |
p. iii-v
|
artikel
|
| 20 |
The neutrophil antigen 3a/b polymorphism in SLC44A2 unexpectedly encodes the Csa/Csb red cell antigens
|
Duval, Romain
|
|
|
146 |
2 |
p. 247-253
|
artikel
|
| 21 |
TTP: a disorder for all physicians
|
George, James N.
|
|
|
146 |
2 |
p. 140-141
|
artikel
|
| 22 |
Unveiling the truth: different names, same antigen
|
Tsuno, Nelson H.
|
|
|
146 |
2 |
p. 141-143
|
artikel
|
| 23 |
When increased bone marrow blasts may not mean malignancy
|
Zaninetti, Carlo
|
|
|
146 |
2 |
p. 143-144
|
artikel
|
Tijdschrift beschrijving